"MedTrust Online is the first, comprehensive Internet-based solution that enables physicians to practise precision medicine", stated Chris Yoo, MedTrust's President and Chief Executive Officer. "We provide clinically-useful knowledge to help physicians find and communicate with each other about cutting-edge cancer treatments for the benefit of their patients."
MedTrust Online is the third company to spin out of TGen Accelerators LLC, a firm designed to quickly translate TGen's genetic research discoveries into medical treatments and services. "While MedTrust is our third spin-off company, it is a first in the informatics area for TGen Accelerator, and marks a beginning in the effort to use the vast knowledge generated by TGen scientists for the commercial benefit of doctors and the general public", stated MaryAnn Guerra, TGen's Chief Business Officer and President of TGen Accelerators.
Richard Love, a former TGen Chief Operating Officer and former CEO of ILEX Oncology Inc., praised the advent of MedTrust as a boost to the local economy. "The creation of MedTrust is part of the promise TGen holds for helping Arizona develop local biomedical expertise, jobs and productive venture partnerships", stated Richard Love, now a Manager for Translational Accelerator LLC, or TRAC, an Arizona-based bioscience venture capital group. "I personally believe that MedTrust can have a bigger positive impact on patient care than anything I've seen come along over the past decade."
TGen and MedTrust Online signed licensing and services agreements on August 5 covering TGen-generated technologies and personnel. MedTrust Online solution will help speed information to oncologists as they seek the best knowledge available about various diseases, especially quality information about potential drug therapies.
The MedTrust Online's Electronic Curbside Consult provides doctors with a platform for discussing difficult cases with experts and promotes peer-to-peer collaboration. Also, MedTrust has formed a partnership with the South Texas Oncology and Hematology (STOH), one of the Southwest's leading cancer care providers. STOH is assisting MedTrust in creating its website, which is expected to go public to doctors starting in December.
In addition, MedTrust has added two key executives to its management team:
- Dr. Leo Otake, a widely published graduate of the Yale University School of Medicine. Dr. Otake has been named Vice President of Medical Informatics. Dr. Otake's primary responsibilities include co-ordinating the collection, organisation and distribution of MedTrust Online content, including peer-reviewed medical journals and pharmaceutical databases. He also will be in charge of managing relationships with oncologists and advisers.
- Russell J. Clark, an attorney with an extensive background in conducting cancer data analytics and creating proprietary tools to identify and analyse patterns of care. Russell J. Clark has been named Executive Vice President of Business Development. Russell J. Clark's primary responsibilities include developing business opportunities and recruiting doctors to subscribe to MedTrust. Russell J. Clark has more than 25 years of experience in health care, legal and business ventures.